However, in vivo, enhanced IL-36γ expression led to significantly stunted growth of all 4 tumor cell lines compared with controls, including the cold and aggressive B16F10 and Renca tumor models (Figure 1A and Supplemental Figure 1C). This evidence concerns the gene IL36G and neoplasm.